Organizer(s): Hongjun Song and Li-Huei TsaiDate: February 22 - 26, 2015
Location: Eldorado Hotel & Spa, Santa Fe, NM, USA
Following the completion of the Human Genome Project, much of biology’s focus has shifted from the raw sequence of genes to their regulation over time and in response to environmental stimuli, in which epigenetics represents a core mechanism. To date, an increasing body of evidence has surfaced indicating that multiple neurological disorders are, in part, caused by aberrant epigenetic modifications. While tremendous progress has been made in understanding epigenetic regulation of gene expression in the nervous system, researchers have yet to learn how the neural epigenome responds to positive (such as learning experiences, enriched environment) and negative (such as epilepsy, injury, stroke) signals as a whole and at the individual gene level, and how the epigenome is regulated at the molecular level. This knowledge is important to better understand normal brain development, plasticity and function and how the epigenome becomes malfunctioned in diseases. Different from proliferating cells commonly studied in epigegenetics, one major subject of the emerging new field of neuroepigenetics deals with various post-mitotic neurons. This Keystone Symposia meeting aims to bring together experts and pioneers in studying neuroepigenetics to provide an up-to-date and comprehensive picture of epigenetic mechanisms in neural development, plasticity, neuronal function and dysfunction. The program for this meeting is highly likely to attract a wide variety of investigators, many of whom might not otherwise interact.
Scholarship Deadline: October 21 2014
Discounted Abstract Deadline: October 21 2014
Abstract Deadline: November 19 2014
Discounted Registration Deadline: December 18 2014
We gratefully acknowledge additional support for this conference from:
$1 - $2,499
neurogenetics (published by Springer)
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:
We gratefully acknowledge the generous grant for this conference provided by:National Institute of Neurological Disorders and Stroke (NINDS)
Grant No. 1R13NS090818-01
The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.